Reinfection – Page 54 – Communicable Diseases Research

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e

Research Article

Published on 2021-01-192022-10-31
Journal: eLife [Category] Coronavirus,

Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission

SARS-CoV-2 재감염 및 전파에 대한 중화 항체의 중요한 역할

Coronaviruses

Published on 2021-01-192022-09-12
Journal: Emerging Microbes & Infections [Category] SARS, 진단,

COVID-19 Reinfection

Family/General Practice

Published on 2021-01-152022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Complete coronavirus disease Course COVID 19 COVID-19 COVID-19 positive patient COVID-19 reinfection covid-19 reinfection in ksa Culture dormant early stage Hypothesis individual ksa covid 19 Mild positive COVID-19 Reinfection reinfection rate reported resolution of symptom returned Swab Symptom Symptoms the disease virus Week
[DOI] 10.7759/cureus.12730 PMC 바로가기 [Article Type] Family/General Practice

Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines

Review

Published on 2021-01-122023-06-15
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] MERS, SARS,

[키워드] long-term immunity Mutation Reinfection Spike protein T-cell Response
[DOI] 10.1016/j.biopha.2021.111272 PMC 바로가기 [Article Type] Review

A first probable case of SARS-CoV-2 reinfection in Colombia

Letter To The Editor

Published on 2021-01-122022-10-28
Journal: Annals of Clinical Microbiology and Antimicrobials [Category] COVID-19, MERS,

[키워드] Reinfection SARS-CoV-2
[DOI] 10.1186/s12941-020-00413-8 PMC 바로가기 [Article Type] Letter To The Editor

Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2

Article

Published on 2021-01-062022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

[키워드] Activation acute respiratory syndrome antibody Antibody Response binding candidate cellular immune responses comparable coronavirus coronavirus disease COVID-19 COVID-19 vaccine death dose doses effective elicit full-length S globular head highest immune responses Immunity immunogenicity induce interferon Limited long-lasting magnitude marker mice Multiple natural infection Neutralizing antibodies Neutralizing antibody response neutralizing antibody responses Pandemics pDNA Plasmid preclinical data Reinfection required robust S-specific antibody SARS-CoV-2 SARS-CoV-2 vaccine Serum level Support translational Undetermined Vaccine viral spike virus Wuhan, China
[DOI] 10.3390/ph14010039 PMC 바로가기 [Article Type] Article

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

SARS-CoV-2 감염 환자에 대한 종단 연구는 중화 항체와 COVID-19 중증도 사이에 높은 상관관계가 있음을 보여줍니다

Article

Published on 2021-01-062022-09-11
Journal: Cellular and Molecular Immunology [Category] Fulltext, MERS, 변종, 진단,

[키워드] absence anti-Spike IgG anti-spike IgG levels antibody Asymptomatic Cohort contribute coronavirus correlated strongly COVID-19 COVID-19 severity Critical cross-neutralization D614G mutation disease disease severity disease symptom elicited Endemic Europe exhibited forms generate had no Health policy heterogeneous high correlation human coronavirus human coronaviruses humoral Humoral response immune correlate immune correlates immune response immune responses individual Infection infections intensive care intensive care unit intensive care units live SARS-CoV-2 Mild symptom mild symptoms NAb NAb activity NAb titers NAbs neutralization neutralizing antibody other coronaviruses Particle Pathogenesis pathogenesis of SARS-CoV-2 Patient Prognostic markers Protective Protein pseudotyped public health qPCR Reinfection required retroviruses reveal SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected patient SARS-CoV-2-infected patients serum sample serum samples spike Spike protein the SARS-CoV-2 the spike protein understanding Vaccine development variant Viral viral infection viral surface
[DOI] 10.1038/s41423-020-00588-2 PMC 바로가기 [Article Type] Article

Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection

Review

Published on 2021-01-052023-07-02
Journal: Journal of advanced research [Category] SARS,

Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol

이스턴 케이프 의료 종사자 SARS-CoV-2(ECHAS) 획득: 횡단면(중첩 코호트) 연구 프로토콜

Protocol

Published on 2021-01-052022-09-10
Journal: International Journal of Environmental Research an [Category] 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 addition African Antenatal antibody antibody assay antibody levels Cape Chain Reaction Clinical characteristics Cluster CMIA Cohort cohort study Community community infection conducted Coronavirus-2 country COVID-19-related death cross-sectional cross-sectional study cumulative decay Department Eastern Cape Effectiveness Fatality rate finding HCW HCWs Health health facilities healthcare worker Healthcare workers highlight humoral immune response identify IgG antibodies IgG antibody immunoassay increased risk independent risk factor independent risk factors Infection Infection prevention infection rate logistic regression models longitudinal change longitudinal changes measure Microparticle offer pandemic participant polymerase chain polymerase chain reaction positive Prevention and control PROTECT Protein qualitative detection questionnaire recruited Regression model Reinfection respiratory reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 RT-PCR SARS-CoV-2 serology SARS-CoV-2 seroprevalence second wave selected serology South South Africa tested the SARS-CoV-2 virulent women worker
[DOI] 10.3390/ijerph18010323 PMC 바로가기 [Article Type] Protocol

SARS-CoV-2 reinfection and implications for vaccine development

Review

Published on 2021-01-042023-06-15
Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS,

[키워드] COVID-19 Reactivation Reinfection SARS-CoV-2 Vaccine
[DOI] 10.1080/21645515.2020.1830683 PMC 바로가기 [Article Type] Review